From: microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
Features | No. (%) | miR-944 expression | P | |
---|---|---|---|---|
(n = 66) | Low, n (%) | High, n (%) | ||
No. of patients | 66 | 41 (62.1) | 25 (37.9) | Â |
Age | Â | Â | Â | 0.815 |
  < 45 years | 20 | 12 (60.0) | 8 (40.0) |  |
  ≥ 45 years | 46 | 29 (63.0) | 17 (37.0) |  |
Histological type | Â | Â | Â | 0.174 |
 ADC | 7 | 6 (85.7) | 1 (12.9) |  |
 SCC | 59 | 35 (59.3) | 24 (40.7) |  |
Tumor size | Â | Â | Â | 0.026 |
  < 4 cm | 30 | 23 (76.7) | 7 (23.3) |  |
  ≥ 4 cm | 36 | 18 (50.0) | 18 (50.0) |  |
FIGO stage | Â | Â | Â | 0.042 |
 IA-IIA | 29 | 22 (75.9) | 7 (24.1) |  |
 IIB-IVB | 37 | 19 (51.4) | 18 (48.6) |  |
Lymph node metastasis | Â | Â | Â | 0.030 |
 No | 35 | 26 (74.3) | 9 (25.7) |  |
 Yes | 31 | 15 (48.4) | 16 (51.6) |  |